Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin

Thangirala Sudha, Murat Yalcin, Hung Yun Lin, Ahmed M. Elmetwally, Tipu Nazeer, Thiruvengadam Arumugam, Patricia Phillips, Shaker A. Mousa

研究成果: 雜誌貢獻文章

14 引文 斯高帕斯(Scopus)

摘要

Sulfated non-anticoagulant heparins (S-NACHs) might be preferred for potential clinical use in cancer patients without affecting hemostasis as compared to low molecular weight heparins (LMWHs). We investigated anti-tumor effects, anti-angiogenesis effects, and mechanisms of S-NACH in a mouse model of pancreatic cancer as compared to the LMWH tinzaparin. S-NACH or tinzaparin with or without gemcitabine were administered, and tumor luminescent signal intensity, tumor weight, and histopathology were assessed at the termination of the study. S-NACH and LMWH efficiently inhibited tumor growth and metastasis, without any observed bleeding events with S-NACH as compared to tinzaparin. S-NACH distinctly increased tumor necrosis and enhanced gemcitabine response in the mouse pancreatic cancer models. These data suggest the potential implication of S-NACH as a neoadjuvant in pancreatic cancer.
原文英語
頁(從 - 到)25-33
頁數9
期刊Cancer Letters
350
發行號1-2
DOIs
出版狀態已發佈 - 八月 1 2014

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

指紋 深入研究「Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin」主題。共同形成了獨特的指紋。

  • 引用此

    Sudha, T., Yalcin, M., Lin, H. Y., Elmetwally, A. M., Nazeer, T., Arumugam, T., Phillips, P., & Mousa, S. A. (2014). Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin. Cancer Letters, 350(1-2), 25-33. https://doi.org/10.1016/j.canlet.2014.04.016